International Patent: MULTISPECIFIC ANTIGEN-BINDING PROTEIN SPECIFICALLY BINDING TO PDL1 AND VEGFR2, AND PROTEIN-DRUG CONJUGATE CONTAINING SAME

GENEVA, Sept. 24 -- JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD. filed a patent application (CN2026/084858) for “MULTISPECIFIC ANTIGEN-BINDING PROTEIN SPECIFICALLY BINDING TO PDL1 AND VEGFR2, AND PROTEIN-DRUG CONJUGATE CONTAINING SAME”. With publication no. WO/2026/195046, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/46

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....